header("Access-Control-Allow-Origin: *"); ?>
therapeuticpublished patents
oncologypublished patents
research tools
diagnosticpublished patents
Welcome to our Technology Offers website You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.
Diagnostic
Research
Therapeutic
Flow Cytometry
Immunocytochemistry
Immunoprecipitation
In vivo studies
Western Blot
Cardiovascular Diseases
Central Nervous System
Dermatology
Ear nose throat disease
Gastrointestinal Diseases
Genetic Disorders
Genito Urinary System
Hematological Disorders
Immunology
Musculoskeletal
Nutritional disorder
Oncology
Ophtalmology
Respiratory Disease
Women health
Others
Infectious diseases
The present invention relates to a method for treating a subject suffering from a cancer comprising a step of administering said subject with a […]
HSP110 is involved in multiple tumorigenic processes, but no inhibitor was known to date. The inventors have identified for the first time HSP110 […]
Immune checkpoint blockade therapy is based on the inhibition of the tumor-mediated suppression of anticancer immune responses. However, the efficacy […]
The response of subjects suffering from cancer to MAPK inhibitors is dramatically impaired by secondary resistances and rapid relapse. So far, the […]
Inventors have generated two human anti-cath-D scFv fragments cloned in the human IgG1 format (F1 and E2) that efficiently bind to human and […]
The present invention relates to methods for enhancing the potency of the immune checkpoint inhibitors. In particular, the present invention relates […]
The invention relates to melanoma antigen named MELOE and their use for preventing, treating and diagnosing melanoma. […]
The present invention relates to the diagnosis of gastrointestinal stromal tumors (GISTs). The present invention also relates to methods and […]
The present invention relates to PD-1 and PD-L1 antibodies to treat cancer […]
The present invention relates to a method of treating disease associated with angiogenesis using an N-Methyl-D-aspartate receptor (NMDA) antagonist. […]
The present invention relates to N-(3-(5-(pyrimidin-4-yl)thiazol-4-yl)phenylsulfonamide compounds […]
The present invention relates to a method for treating a subject suffering from a cancer comprising […]
In this study, the Inventors report that CD9 is a key component of PC-associated CAFsderived […]
Several gastrointestinal and gynecological malignancies have the potential to disseminate and grow […]
T-cell lymphomas are a heterogeneous group of malignancies involving T lymphocytes and generally […]
Inventors analyzed the prognostic value of tumor and stromal-derived SPARC in a large series that […]
The present invention relates to the diagnosing of colorectal cancer. The inventors have thus […]
Investigating the impact of Tau protein expression in cancer cell lines, Inventors have demonstrated […]
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore […]
The present invention relates to the prediction of the survival time of a patient suffering of a […]
Research tool licensing team
researchtools@inserm-transfert.fr
User accounts are momentarily unavailable
The Inserm Transfert website is currently undergoing maintenance. It will be available again in a few hours.